Showing 491-500 of 8854 results for "".
Analysis Evaluates Risks of Cardiovascular Events Among Biologics for Psoriatic Diseases
https://practicaldermatology.com/series/dermwire-tv/analysis-evaluates-risks-of-cardiovascular-events-among-biologics-for-psoriatic-diseases/32412/In this week's DermwireTV, a new analysis evaluates the risks of major adverse cardiovascular events among patients treated with biologics for psoriatic diseases; a phase 3 clinical trial examines the use of nemolizumab in adults with prurigo nodularis; and the president of Journey Medical discussesSDPA: Sara Wilchowski Talks About Transitioning to Industry and Understanding How Nutraceuticals Can Help Patients
https://practicaldermatology.com/conferences/sdpa-2024/sdpa-sara-wilchowski-talks-about-transitioning-to-industry-and-understanding-how-nutraceuticals-can-help-patients/29513/At the SDPA 22nd Annual Fall Dermatology Conference, Practical Dermatology caught up with Sara Wilchowski, DMSc, MPAS, PA-C. Wilchowski is currently a senior medical science liaison and joined a panel of MSLs to discuss the ins and outs of transitioning to industry. Following the panel, she gave a lFDA Approves Botox for Vertical Platysma Bands
https://practicaldermatology.com/series/dermwire-tv/fda-approves-botox-vertical-platysma-bands/29127/In this week's DermwireTV, Botox is approved for its fourth aesthetic indication in the US; the FDA clears a new laser for the long-term treatment of patients with acne vulgaris; and the Chief Scientific Officer of Leo Pharma talks about treatment options for chronic hand eczema.Eczema Awareness Month
https://practicaldermatology.com/series/updates-atopic-dermatitis/eczema-awareness-month/29082/Dr. Peter Lio, Clinical Assistant Professor at Northwestern University's Feinberg School of Medicine, talks with Practical Dermatology about Eczema Awareness Month and the strides that have been made in awareness of atopic dermatitis.Innovations in the Aesthetic Market and Wrinkle Removal Technology
https://practicaldermatology.com/series/c-suite-chats/innovations-aesthetic-market-and-wrinkle-removal-technology/26732/Lou Scafuri, CEO of SofWave Medical, talks about what makes the company’s Synchronous Ultrasound Parallel Beam technology unique.FDA Approves New AD Treatment; Study Examines Omega-3 Fatty Acids in Managing Acne
https://practicaldermatology.com/series/dermwire-tv/fda-approves-new-ad-treatment-study-examines-omega-3-fatty-acids-managing-acne/26664/In this week’s DermwireTV, a new steroid-free treatment option for children and adults living with AD is approved by the FDA; research examines the potential benefits of omega-3 fatty acids in managing acne severity; Modern Aesthetics announces plans to relaunch its news broadcast; and Andrew MastroJonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uActive Vitiligo: What to Look For
https://practicaldermatology.com/series/updates-vitiligo/active-vitiligo-what-to-look-for/24156/John E. Harris, MD, founding director of the Autoimmune Therapeutics Institute at the University of Massachusetts Chan Medical School, talks with Practical Dermatology Chief Medical Editor Neal Bhatia, MD, about the clinical signs of active vitiligo.DermWireTV: Spevigo for GPP; Derms on Acne Experience; IFPA Takes PsO to the Gaming World; La Roche-Posay at the US Open
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-spevigo-for-gpp-derms-on-acne-experience-ifpa-takes-pso-to-the-gaming-world-la-roche-posay-at-the-us-open/20136/Boehringer Ingelheim’s Spevigo is the first FDA-approved treatment option for generalized pustular psoriasis (GPP) flares in adults. Spesolimab is a novel, selective antibody that blocks the activation of the interleukin-36 receptor. Dermatologists, dermatology physician assistants, and dermatologySEO basics- Google ranking factors that you can’t afford to ignore
https://practicaldermatology.com/topics/practice-management/seo-basics-google-ranking-factors-that-you-cant-afford-to-ignore/20086/Are you overwhelmed by the abundance of SEO tips and Google ranking factors? At a loss for where to focus your efforts? Check out this video from Ekwa Marketing (www.ekwa.com) for the shortlist of what really matters in dermatology marketing.